Anteris Technologies Global Corp. — Board/Management Information 2018

Nov 25, 2018

26 November 2018

==> picture [451 x 24] intentionally omitted <==

ASX ANNOUNCEMENT

ADMEDUS APPOINTS MATTHEW MCDONNELL AS INTERIM CFO

Medical technology company Admedus Ltd (ASX: AHZ) has appointed former KPMG partner Matthew McDonnell as its interim CFO.

With over 24 years at KPMG, including 10 years as a partner, Mr McDonnell brings a broad range of industry experience and corporate governance acumen, having delivered audit, accounting and advisory services across a wide range of sectors.

At KPMG, Mr McDonnell worked in both Australia and the US, covering financial services, transport, industrial markets, health, childcare and energy. He has experience in restructures, acquisitions, divestments, privatisations and other significant financial transactions.

Mr McDonnell was notably involved in Queensland Government restructures and privatisations; Linc Energy’s re-listing on the Singapore Exchange; acquisitions such as Virgin Australia’s purchase of Skywest. He was also Director of the State Library of Queensland and was Chair of the Audit and Risk Management Committee for eight years.

“I am very pleased to welcome a manager of Matthew’s calibre to our executive team,” said Wayne Paterson, Admedus CEO.

“His presence in the management team will add significant value to the strategic finance process. Matthew’s multi-industry global experience will help us execute our capital management strategy as we enter our next phase of growth and development

“Being highly skilled in governance, managerial finance, technical accounting matters and risk management, Matthew’s input will bring enormous advantage to Admedus and its shareholders, as we continue to grow global sales of our ADAPT® portfolio, and advance our product development program.”

Mr McDonnell is also a chartered accountant and holds a Bachelor of Economics from Macquarie University in NSW. Mr McDonnell commenced his role in Brisbane on Friday 23 November 2018.

Admedus Limited

Registered Office: Level 9, 301 Coronation Drive, Milton, Queensland 4064

==> picture [72 x 72] intentionally omitted <==

Customer Service:

T: 1300 550 310 F: 1300 880 398 International: T: +61 (0)7 3152 3200 F: +61 (0)7 3152 3299 E: info@admedus.com W: admedus.com

Brisbane • Minneapolis • Geneva • Singapore

ABN 35 088 221 078

==> picture [451 x 24] intentionally omitted <==

ENDS

About Admedus Limited

Admedus (ASX:AHZ) is a medical technologies company delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. Our focus is on investing in and developing next-generation technologies with world-class partners, acquiring strategic assets to grow product and service offerings, and expanding revenues from our existing medical sales and distribution business. The Company has assets from research & development through clinical development and sales, marketing and distribution.

Website: www.admedus.com Facebook: www.facebook.com/Admedus Twitter: @Admedus

For more information, please contact:

Admedus@we-buchan.com

==> picture [21 x 19] intentionally omitted <==